173 related articles for article (PubMed ID: 9612606)
1. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
Traub WH; Geipel U; Leonhard B
Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
[TBL] [Abstract][Full Text] [Related]
6. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
Pankuch GA; Jacobs MR; Rittenhouse SF; Appelbaum PC
Antimicrob Agents Chemother; 1994 Oct; 38(10):2317-22. PubMed ID: 7840563
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
[TBL] [Abstract][Full Text] [Related]
8. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
9. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Moraxella catarrhalis to 21 antimicrobial drugs: validity of current NCCLS criteria for the interpretation of agar disk diffusion antibiograms.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(3):159-67. PubMed ID: 9142455
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium.
Traub WH; Geipel U; Leonhard B; Bauer D
Chemotherapy; 1998; 44(4):230-7. PubMed ID: 9681199
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.
Nicodemo AC; Araujo MR; Ruiz AS; Gales AC
J Antimicrob Chemother; 2004 Apr; 53(4):604-8. PubMed ID: 14973153
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Ismaeel NA
Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
[TBL] [Abstract][Full Text] [Related]
17. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
Smit WJ; Boquest AL; Geddes JE; Tosolini FA
Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.
Hohl P; Frei R; Aubry P
Diagn Microbiol Infect Dis; 1991; 14(5):447-50. PubMed ID: 1797460
[TBL] [Abstract][Full Text] [Related]
19. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.
Yao JD; Louie M; Louie L; Goodfellow J; Simor AE
J Clin Microbiol; 1995 May; 33(5):1428-30. PubMed ID: 7615774
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.
Lecso-Bornet M; Bergogne-Bérézin E
J Antimicrob Chemother; 1997 Nov; 40(5):717-20. PubMed ID: 9421322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]